PEAK6 Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$591K Buy
27,200
+22,000
+423% +$430K ﹤0.01% 2439
2018
Q1
$92K Buy
5,200
+5,000
+2,500% +$88.1K ﹤0.01% 3752
2017
Q4
$4K Sell
200
-12,700
-98% -$253K ﹤0.01% 3973
2017
Q3
$283K Sell
12,900
-11,600
-47% -$262K ﹤0.01% 3016
2017
Q2
$590K Buy
24,500
+17,900
+271% +$455K ﹤0.01% 2382
2017
Q1
$184K Sell
6,600
-1,300
-16% -$34.1K ﹤0.01% 3146
2016
Q4
$193K Buy
7,900
+6,800
+618% +$156K ﹤0.01% 3396
2016
Q3
$28K Buy
+1,100
New +$26.4K ﹤0.01% 4036

Other funds holding SBRA

PEAK6 Group's SBRA Position: Q3 2017 in Review

PEAK6 Group sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 2,588 shares — an estimated $58.5K sold.

PEAK6 Group first reported a position in SBRA in Q2 2017 and held it in 1 quarter. The position peaked at $62K in Q2 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

  • PEAK6 Group reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 2,588 Sabra Healthcare REIT shares in Q3 2017, an estimated $58.5K.
  • PEAK6 Group first reported a position in Sabra Healthcare REIT in Q2 2017 and held it in 1 quarter.
  • PEAK6 Group's Sabra Healthcare REIT position peaked at $62K in Q2 2017.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.